marketcaparena
Search

    VTAK

    Catheter Precision, Inc.

    Company overview

    Market capitalization
    $2.11M
    Employees
    17
    Latest publication
    2026-09-29
    About Catheter Precision, Inc.

    Catheter Precision, Inc. designs, manufactures, and sells medical technologies for the field of cardiac electrophysiology (EP) in the United States and Europe. The company's lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures; and LockeT, a suture retention device that temporarily secure sutures and aid clinicians in locating and removing sutures. Catheter Precision, Inc. was formerly known as Catheter Robotics Inc. The company is based in Fort Mill, South Carolina.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Revenue1,019,000USD432,000USD238,000USD226,000USD212,000USD143,000USD149,000USD96,000USD
    Cost Of Revenue921,000USD544,000USD20,000USD18,000USD14,000USD11,000USD11,000USD10,000USD
    Gross Profit98,000USD-112,000USD218,000USD208,000USD198,000USD132,000USD138,000USD86,000USD
    Research Development142,000USD149,000USD328,000USD276,000USD155,000USD103,000USD91,000USD63,000USD
    Selling General Administrative3,911,000USD2,559,000USD2,756,000USD2,953,000USD2,881,000USD3,485,000USD3,098,000USD2,882,000USD
    Total Operating Expenses4,053,000USD2,206,000USD3,084,000USD3,229,000USD3,036,000USD3,588,000USD3,189,000USD2,945,000USD
    Operating Income-3,955,000USD-2,318,000USD-2,866,000USD-3,021,000USD-2,838,000USD-3,456,000USD-3,051,000USD-2,859,000USD
    Total Other Income Expense Net337,000USD453,000USD-3,196,000USD755,000USD-3,570,000USD-1,313,000USD564,000USD-1,261,000USD
    Interest Income4,000USD2,000USD3,000USD10,000USD3,000USD18,000USD34,000USD7,000USD
    Income Before Tax-3,618,000USD-1,865,000USD-6,062,000USD-2,266,000USD-6,408,000USD-4,769,000USD-2,487,000USD-4,120,000USD
    Income Tax Expense-312,000USD-175,000USD-214,000USD78,000USD-950,000USD-724,000USD3,141,000USD-4,120,000USD
    Net Income-3,306,000USD-1,681,000USD-5,336,000USD-2,344,000USD-5,458,000USD-4,045,000USD-5,628,000USD-4,120,000USD
    Minority Interest-11,000USD9,000USD———0USD——
    Net Income Applicable To Common Shares-2,555,000USD———————
    Interest Expense—119,000USD82,000USD83,000USD67,000USD49,000USD51,000USD32,000USD
    Net Interest Income—-117,000USD-79,000USD-73,000USD-64,000USD-31,000USD-17,000USD-25,000USD
    Tax Provision—-175,000USD-214,000USD78,000USD-950,000USD-724,000USD—0USD
    Net Income From Continuing Ops—-1,690,000USD-5,848,000USD-2,344,000USD-5,458,000USD-4,045,000USD-5,628,000USD-4,120,000USD
    Ebit—-2,318,000USD-5,980,000USD-2,183,000USD-6,341,000USD-4,720,000USD-2,436,000USD-4,088,000USD
    Ebitda—-1,816,000USD-5,453,000USD-1,655,000USD-5,812,000USD-4,189,000USD-1,905,000USD-3,569,000USD
    Depreciation And Amortization—502,000USD527,000USD528,000USD529,000USD531,000USD531,000USD519,000USD
    Reconciled Depreciation—502,000USD527,000USD528,000USD529,000USD531,000USD531,000USD530,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Revenue819,000USD420,000USD442,000USD14,000USD22,000USD4,405,000USD7,199,000USD6,257,000USD
    Cost Of Revenue63,000USD42,000USD30,000USD161,000USD1,560,000USD5,482,000USD8,850,000USD4,206,000USD
    Gross Profit756,000USD378,000USD412,000USD-147,000USD-1,538,000USD-1,077,000USD-1,651,000USD2,051,000USD
    Research Development862,000USD272,000USD475,000USD6,392,000USD12,253,000USD9,008,000USD4,530,000USD2,776,000USD
    Selling General Administrative12,075,000USD11,349,000USD17,122,000USD2,232,936USD15,475,000USD25,974,000USD51,549,000USD30,435,000USD
    Total Operating Expenses12,937,000USD11,621,000USD78,531,000USD26,814,000USD27,728,000USD34,982,000USD56,079,000USD33,211,000USD
    Operating Income-12,181,000USD-11,243,000USD-78,119,000USD-26,961,000USD-29,266,000USD-36,059,000USD-57,730,000USD-31,160,000USD
    Interest Income34,000USD81,000USD347,000USD0USD—129,000USD1,038,000USD—
    Interest Expense281,000USD91,000USD0USD3,077,724USD10,000USD108,000USD250,000USD14,000USD
    Net Interest Income-247,000USD-10,000USD347,000USD0USD—21,000USD788,000USD—
    Income Before Tax-19,505,000USD-13,502,000USD-70,572,000USD-26,862,000USD-27,257,000USD-36,038,000USD-56,942,000USD-30,822,000USD
    Income Tax Expense-1,810,000USD3,141,000USD60,587,000USD3,000USD4,000USD7,000USD15,000USD10,000USD
    Tax Provision-1,810,000USD3,141,000USD0USD3,000USD4,000USD7,000USD15,000USD—
    Net Income-17,183,000USD-16,643,000USD-70,572,000USD-26,865,000USD-25,070,000USD-36,045,000USD-56,957,000USD-30,832,000USD
    Net Income From Continuing Ops-17,695,000USD-16,643,000USD-70,572,000USD-26,865,000USD-27,261,000USD-36,045,000USD-56,957,000USD—
    Ebit-19,224,000USD-13,411,000USD-17,185,000USD-22,789,000USD-29,266,000USD-36,059,000USD-57,730,000USD-31,160,000USD
    Ebitda-17,109,000USD-11,302,000USD-15,110,000USD-22,368,000USD-27,701,000USD-33,694,000USD-55,980,000USD-30,536,000USD
    Depreciation And Amortization2,115,000USD2,109,000USD2,075,000USD421,000USD1,565,000USD2,365,000USD1,750,000USD624,000USD
    Reconciled Depreciation2,115,000USD2,109,000USD2,075,000USD421,000USD1,565,000USD2,365,000USD1,750,000USD—
    Total Other Income Expense Net-7,324,000USD-2,259,000USD7,547,000USD99,000USD2,009,000USD21,000USD788,000USD338,000USD
    Minority Interest512,000USD———————
    Unclassified Operating Expenses——60,934,000USD16,936,591USD————
    Selling And Marketing Expenses———1,252,473USD————
    Discontinued Operations————2,191,000USD-725,000USD——
    Net Income Applicable To Common Shares————-25,070,000USD-36,045,000USD——
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets36,870,000USD35,085,000USD15,860,000USD25,473,000USD25,563,000USD24,800,000USD27,770,000USD26,745,000USD
    Cash And Equivalents643,000USD———————
    Cash And Short Term Investments1,839,000USD441,000USD88,000USD1,075,000USD1,712,000USD450,000USD2,873,000USD1,268,000USD
    Short Term Investments1,196,000USD——981,000USD874,000USD———
    Total Current Assets2,510,000USD1,249,000USD390,000USD2,467,000USD2,046,000USD854,000USD3,292,000USD1,714,000USD
    Other Current Assets463,000USD485,000USD61,000USD1,235,000USD171,000USD248,000USD316,000USD307,000USD
    Other Non Current Assets160,000USD———————
    Total Liabilities19,732,000USD———————
    Total Current Liabilities13,452,000USD19,738,000USD3,907,000USD5,325,000USD4,642,000USD4,089,000USD2,085,000USD2,586,000USD
    Other Current Liabilities1,982,000USD———————
    Total Stockholder Equity17,561,000USD9,569,000USD7,054,000USD6,782,000USD6,789,000USD7,916,000USD11,757,000USD12,826,000USD
    Total Equity Including Noncontrolling Interest17,138,000USD———————
    Deferred Revenue145,000USD———————
    Net Receivables120,000USD261,000USD155,000USD123,000USD115,000USD85,000USD70,000USD107,000USD
    Inventory88,000USD62,000USD86,000USD34,000USD48,000USD71,000USD33,000USD32,000USD
    Property Plant Equipment Net2,637,000USD1,760,000USD226,000USD256,000USD257,000USD175,000USD196,000USD238,000USD
    Goodwill12,962,000USD———————
    Intangible Assets18,601,000USD22,295,000USD15,236,000USD22,742,000USD23,252,000USD23,763,000USD24,274,000USD24,785,000USD
    Accounts Payable1,447,000USD1,079,000USD1,492,000USD1,079,000USD804,000USD647,000USD230,000USD708,000USD
    Short Term Debt1,474,000USD8,048,000USD667,000USD2,070,000USD2,305,000USD1,791,000USD275,000USD348,000USD
    Common Stock0USD———————
    Retained Earnings-314,511,000USD-311,216,000USD-309,535,000USD-303,757,000USD-301,506,000USD-296,397,000USD-292,352,000USD-286,724,000USD
    Total Liab—25,928,000USD9,209,000USD19,024,000USD19,014,000USD16,884,000USD16,013,000USD13,919,000USD
    Other Current Liab—10,485,000USD1,748,000USD2,176,000USD1,533,000USD1,651,000USD1,580,000USD1,530,000USD
    Capital Stock—0USD0USD0USD0USD0USD0USD0USD
    Good Will—9,725,000USD——————
    Cash—441,000USD88,000USD1,075,000USD838,000USD450,000USD2,873,000USD1,268,000USD
    Current Deferred Revenue—126,000USD——————
    Net Debt—11,553,000USD3,758,000USD2,406,000USD2,826,000USD11,720,000USD-1,085,000USD616,000USD
    Short Long Term Debt—7,147,000USD604,000USD1,999,000USD2,219,000USD1,708,000USD177,000USD249,000USD
    Short Long Term Debt Total—11,994,000USD3,846,000USD3,481,000USD3,664,000USD12,170,000USD1,788,000USD1,884,000USD
    Long Term Debt—3,214,000USD3,078,000USD1,297,000USD1,265,000USD—1,500,000USD1,500,000USD
    Property Plant Equipment Gross—1,943,000USD395,000USD408,000USD392,000USD292,000USD293,000USD315,000USD
    Common Stock Shares Outstanding—2,191,831,000shares1,080,617,000shares13,205,540shares13,336,088shares11,283,929shares8,004,633shares2,050,947shares
    Non Current Assets Total—33,836,000USD15,470,000USD23,006,000USD23,517,000USD23,946,000USD24,478,000USD25,031,000USD
    Non Current Liabilities Total—6,190,000USD5,302,000USD13,699,000USD14,372,000USD12,795,000USD13,928,000USD11,333,000USD
    Non Currrent Assets Other—56,000USD8,000USD8,000USD8,000USD8,000USD8,000USD8,000USD
    Net Working Capital—-18,489,000USD-3,517,000USD-2,858,000USD-2,596,000USD-3,235,000USD1,207,000USD-872,000USD
    Unclassified Current Liabilities—-7,147,000USD—-1,999,000USD-2,219,000USD-1,708,000USD——
    Unclassified Non Current Liabilities—2,976,000USD2,224,000USD12,402,000USD13,107,000USD12,795,000USD12,428,000USD9,833,000USD
    Unclassified Equity—320,785,000USD316,589,000USD310,539,000USD308,295,000USD304,313,000USD304,109,000USD299,550,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets15,860,000USD27,770,000USD30,736,000USD16,836,000USD21,044,000USD33,438,000USD44,081,000USD74,035,000USD
    Intangible Assets15,236,000USD24,274,000USD26,318,000USD—————
    Other Current Assets61,000USD316,000USD415,000USD977,000USD1,037,000USD2,813,000USD1,860,000USD1,501,000USD
    Total Liab9,209,000USD16,013,000USD9,543,000USD7,576,000USD7,371,000USD12,291,000USD10,931,000USD7,330,000USD
    Total Stockholder Equity7,054,000USD11,757,000USD21,193,000USD9,260,000USD13,673,000USD21,147,000USD33,150,000USD66,705,000USD
    Other Current Liab1,748,000USD1,580,000USD1,733,000USD7,484,000USD4,119,000USD4,448,000USD2,642,000USD2,809,000USD
    Capital Stock0USD0USD0USD0USD8,000USD7,000USD1,000USD—
    Retained Earnings-309,535,000USD-292,352,000USD-275,709,000USD-205,137,000USD-178,272,000USD-153,202,000USD-117,157,000USD-60,221,000USD
    Cash88,000USD2,873,000USD3,565,000USD15,859,000USD15,045,000USD23,906,000USD14,584,000USD64,315,000USD
    Cash And Short Term Investments88,000USD2,873,000USD3,565,000USD15,859,000USD15,045,000USD23,906,000USD30,577,000USD64,315,000USD
    Total Current Assets390,000USD3,292,000USD4,161,000USD16,836,000USD17,089,000USD27,620,000USD36,000,000USD69,233,000USD
    Total Current Liabilities3,907,000USD2,085,000USD2,472,000USD7,576,000USD5,390,000USD7,762,000USD6,814,000USD5,950,000USD
    Net Debt3,758,000USD-1,085,000USD-3,193,000USD-15,859,000USD-12,781,000USD-19,021,000USD-11,088,000USD-63,465,000USD
    Short Term Debt667,000USD275,000USD275,000USD36,654USD283,000USD1,042,000USD611,000USD293,000USD
    Short Long Term Debt604,000USD177,000USD184,000USD——686,000USD293,000USD—
    Short Long Term Debt Total3,846,000USD1,788,000USD372,000USD124,167USD2,264,000USD4,885,000USD3,496,000USD850,000USD
    Long Term Debt3,078,000USD1,500,000USD———1,579,000USD265,000USD—
    Net Receivables155,000USD70,000USD137,000USD75,586USD21,000USD24,000USD786,000USD1,320,000USD
    Inventory86,000USD33,000USD44,000USD52,408USD986,000USD877,000USD2,777,000USD2,097,000USD
    Accounts Payable1,492,000USD230,000USD464,000USD92,000USD988,000USD471,000USD1,532,000USD1,125,000USD
    Property Plant Equipment Net226,000USD196,000USD249,000USD144,955USD3,919,000USD5,695,000USD7,885,000USD4,757,000USD
    Property Plant Equipment Gross395,000USD293,000USD281,000USD0USD3,919,000USD5,695,000USD7,885,000USD—
    Common Stock Shares Outstanding1,080,617,000shares3,263,586shares5,495,070shares1,034,000shares101,000shares33,980shares10,516shares7,384shares
    Non Current Assets Total15,470,000USD24,478,000USD26,575,000USD144,955USD3,955,000USD5,818,000USD8,081,000USD4,802,000USD
    Non Current Liabilities Total5,302,000USD13,928,000USD7,071,000USD246,969USD1,981,000USD4,529,000USD4,117,000USD1,380,000USD
    Non Currrent Assets Other8,000USD8,000USD8,000USD—36,000USD123,000USD196,000USD45,000USD
    Net Working Capital-3,517,000USD1,207,000USD1,689,000USD9,260,000USD11,699,000USD19,858,000USD29,186,000USD—
    Unclassified Non Current Liabilities2,224,000USD12,428,000USD7,070,000USD—1,981,000USD2,264,000USD3,852,000USD1,380,000USD
    Unclassified Equity316,589,000USD304,109,000USD296,901,000USD214,386,904USD191,929,000USD174,335,000USD150,279,000USD128,238,000USD
    Common Stock——1,000USD10,096USD8,000USD7,000USD1,000USD1,000USD
    Non Current Liabilities Other——1,000USD—————
    Other Assets———-144,955USD36,000USD807,000USD——
    Net Tangible Assets————13,673,000USD21,147,000USD——
    Other Liab—————686,000USD——
    Current Deferred Revenue—————1,801,000USD2,029,000USD1,723,000USD
    Short Term Investments—————0USD15,993,000USD—
    Accumulated Other Comprehensive Income——————26,000USD-1,313,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow YTD

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USD
    Depreciation787,000USD
    Stock Based Compensation330,000USD
    Deferred Income Tax-486,000USD
    Other Non Cash Items-105,000USD
    Change To Account Receivables36,000USD
    Change To Inventory-12,000USD
    Change To Liabilities-118,000USD
    Change In Working Capital-553,000USD
    Operating Cash Flow-5,657,000USD
    Capital Expenditures-21,000USD
    Net Investments-818,000USD
    Unclassified Investing Cash Flow-1,313,000USD
    Investing Cash Flow-2,152,000USD
    Financing Cash Flow8,364,000USD
    Change In Cash555,000USD
    End Cash Flow643,000USD
    SourceDisclosureDeterministicFinal

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income-1,681,000USD-5,848,000USD-2,251,000USD-5,458,000USD-4,045,000USD-5,628,000USD-4,120,000USD-4,220,000USD
    Depreciation502,000USD527,000USD528,000USD529,000USD531,000USD531,000USD519,000USD526,000USD
    Stock Based Compensation64,000USD79,000USD70,000USD98,000USD91,000USD18,000USD17,000USD13,000USD
    Other Non Cash Items-492,000USD3,139,000USD-839,000USD3,515,000USD1,282,000USD2,557,000USD1,570,000USD1,504,000USD
    Change To Account Receivables-105,000USD-32,000USD-8,000USD-29,000USD-16,000USD37,000USD-2,000USD-32,000USD
    Change To Inventory19,000USD-57,000USD4,000USD18,000USD-43,000USD-1,000USD12,000USD0USD
    Change In Working Capital-909,000USD805,000USD308,000USD3,000USD527,000USD-342,000USD-438,000USD480,000USD
    Total Cash From Operating Activities-2,754,000USD-1,512,000USD-2,176,000USD-2,263,000USD-2,338,000USD-2,864,000USD-2,469,000USD-1,697,000USD
    Capital Expenditures-6,000USD-82,000USD-7,000USD-13,000USD-10,000USD0USD-1USD-45,000USD
    Free Cash Flow-2,760,000USD-1,594,000USD-2,176,000USD-2,276,000USD-2,348,000USD-2,864,000USD-2,469,000USD-1,742,000USD
    Total Cashflows From Investing Activities-1,319,000USD218,000USD-28,000USD-13,000USD-10,000USD——-45,000USD
    Net Borrowings336,000USD300,000USD274,000USD-76,000USD-75,000USD-72,000USD1,099,000USD—
    Total Cash From Financing Activities4,426,000USD307,000USD2,441,000USD2,664,000USD-75,000USD4,469,000USD3,721,000USD267,000USD
    Dividends Paid-1,360,000USD———-5,158,000USD-5,158,000USD——
    Issuance Of Capital Stock3,731,000USD7,000USD2,174,000USD2,740,000USD0USD3,356,000USD2,612,000USD0USD
    Change In Cash353,000USD-987,000USD237,000USD388,000USD-2,423,000USD1,605,000USD1,252,000USD-1,475,000USD
    Begin Period Cash Flow88,000USD1,075,000USD838,000USD450,000USD2,873,000USD1,268,000USD16,000USD1,491,000USD
    End Period Cash Flow441,000USD88,000USD1,075,000USD838,000USD450,000USD2,873,000USD1,268,000USD16,000USD
    Other Cashflows From Investing Activities-103,000USD-82,000USD-34,000USD-6,000USD————
    Other Cashflows From Financing Activities1USD307,000USD5,112,000USD2,740,000USD11,000USD1,185,000USD10,000USD-309,000USD
    Unclassified Investing Cash Flow-1,210,000USD———————
    Unclassified Financing Cash Flow1,718,999USD—-5,119,000USD-2,740,000USD5,147,000USD5,158,000USD——
    Investments——-28,000USD-13,000USD-10,000USD0USD0USD-45,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income-17,183,000USD-16,643,000USD-70,572,000USD-26,865,000USD-25,070,000USD-36,045,000USD-56,957,000USD-30,832,000USD
    Depreciation2,115,000USD2,109,000USD2,075,000USD421,000USD1,565,000USD2,365,000USD1,750,000USD624,000USD
    Stock Based Compensation338,000USD54,000USD1,217,000USD447,000USD2,237,000USD4,082,000USD23,543,000USD14,728,000USD
    Other Non Cash Items6,608,000USD2,239,000USD53,726,000USD2,817,000USD-5,999,000USD279,000USD406,000USD255,000USD
    Change To Account Receivables-85,000USD67,000USD-66,000USD-59,193USD42,000USD368,000USD251,000USD-1,058,000USD
    Change To Inventory-78,000USD-8,000USD8,000USD-14,000USD-197,000USD352,000USD-2,185,000USD-3,874,000USD
    Change In Working Capital1,636,000USD-171,000USD-7,065,000USD547,000USD-358,000USD1,015,000USD-1,915,000USD-3,283,000USD
    Total Cash From Operating Activities-8,296,000USD-9,271,000USD-20,619,000USD-22,568,000USD-27,625,000USD-28,304,000USD-33,173,000USD-18,508,000USD
    Capital Expenditures-17,000USD-67,000USD-76,000USD-17,000USD-265,000USD-67,000USD-268,000USD-582,000USD
    Free Cash Flow-8,313,000USD-9,338,000USD-20,695,000USD-22,585,000USD-27,890,000USD-28,371,000USD-33,441,000USD-19,090,000USD
    Investments300,000USD-67,000USD-61,000USD21,000USD3,802,000USD15,933,000USD-16,032,000USD—
    Total Cashflows From Investing Activities167,000USD-67,000USD-61,000USD21,000USD3,802,000USD15,933,000USD-16,032,000USD-582,000USD
    Net Borrowings423,000USD1,493,000USD-357,000USD0USD-265,000USD1,707,000USD——
    Total Cash From Financing Activities5,344,000USD8,646,000USD8,386,000USD23,361,000USD14,962,000USD21,693,000USD-526,000USD75,168,000USD
    Issuance Of Capital Stock4,921,000USD5,968,000USD8,238,000USD18,906,000USD15,528,000USD19,887,000USD37,000USD—
    Change In Cash-2,785,000USD-692,000USD-12,294,000USD814,000USD-8,861,000USD9,322,000USD-49,731,000USD56,078,000USD
    Begin Period Cash Flow2,873,000USD3,565,000USD15,859,000USD15,045,000USD23,906,000USD14,584,000USD64,315,000USD8,237,000USD
    End Period Cash Flow88,000USD2,873,000USD3,565,000USD15,859,000USD15,045,000USD23,906,000USD14,584,000USD64,315,000USD
    Other Cashflows From Investing Activities-116,000USD——38,000USD4,067,000USD3,473,000USD——
    Other Cashflows From Financing Activities1,170,000USD1,185,000USD505,000USD5,362,161USD-301,000USD99,000USD-225,000USD-3,556,000USD
    Unclassified Operating Cash Flow-1,810,000USD3,141,000USD——————
    Unclassified Financing Cash Flow-1,170,000USD5,158,000USD—————78,724,000USD
    Dividends Paid—-5,158,000USD—-907,161USD————
    Change To Liabilities————393,000USD-1,735,000USD——
    Unclassified Investing Cash Flow————-3,802,000USD-3,406,000USD——
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q1 2026Quarterly · 2026-03-31ProductProduct248,000USD0001437749-26-017509
    Q1 2026Quarterly · 2026-03-31ProductServices184,000USD0001437749-26-017509
    Q1 2026Quarterly · 2026-03-31ProductSoftware Upgrade Services0USD0001437749-26-017509
    Q1 2026Quarterly · 2026-03-31SegmentCardiac Electrophysiology248,000USD0001437749-26-017509
    Q1 2026Quarterly · 2026-03-31SegmentPrivate Aviation184,000USD0001437749-26-017509
    Q4 2025Quarterly · 2025-12-31GeographyEurope63,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31GeographyUnited States175,000USDLegacy provider
    FY 2025Yearly · 2025-12-31GeographyEurope164,000USD0001437749-26-010549
    FY 2025Yearly · 2025-12-31GeographyUnited States655,000USD0001437749-26-010549
    FY 2025Yearly · 2025-12-31ProductProduct819,000USD0001437749-26-010549
    FY 2025Yearly · 2025-12-31ProductSoftware Upgrade Services0USD0001437749-26-010549
    Q3 2025Quarterly · 2025-09-30GeographyEurope54,000USD0001437749-25-034841
    Q3 2025Quarterly · 2025-09-30GeographyUnited States172,000USD0001437749-25-034841
    Q2 2025Quarterly · 2025-06-30GeographyEurope39,000USD0001437749-25-025933
    Q2 2025Quarterly · 2025-06-30GeographyUnited States173,000USD0001437749-25-025933
    Q1 2025Quarterly · 2025-03-31ProductProduct143,000USD0001437749-26-017509
    Q1 2025Quarterly · 2025-03-31ProductServices0USD0001437749-26-017509
    Q1 2025Quarterly · 2025-03-31ProductSoftware Upgrade Services0USD0001437749-26-017509
    Q1 2025Quarterly · 2025-03-31GeographyEurope8,000USD0001437749-25-016850
    Q1 2025Quarterly · 2025-03-31GeographyUnited States135,000USD0001437749-25-016850
    Q4 2024Quarterly · 2024-12-31GeographyEurope1,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31GeographyUnited States148,000USDLegacy provider
    FY 2024Yearly · 2024-12-31GeographyEurope142,000USD0001437749-26-010549
    FY 2024Yearly · 2024-12-31GeographyUnited States278,000USD0001437749-26-010549
    FY 2024Yearly · 2024-12-31ProductProduct420,000USD0001437749-26-010549
    FY 2024Yearly · 2024-12-31ProductSoftware Upgrade Services0USD0001437749-26-010549
    Q3 2024Quarterly · 2024-09-30GeographyEurope34,000USD0001437749-25-034841
    Q3 2024Quarterly · 2024-09-30GeographyUnited States62,000USD0001437749-25-034841
    Q2 2024Quarterly · 2024-06-30GeographyEurope33,000USD0001437749-25-025933
    Q2 2024Quarterly · 2024-06-30GeographyUnited States60,000USD0001437749-25-025933
    Q1 2024Quarterly · 2024-03-31ProductProduct82,000USD0001437749-25-016850
    Q1 2024Quarterly · 2024-03-31ProductSoftware Upgrade Services0USD0001437749-25-016850
    Q1 2024Quarterly · 2024-03-31GeographyEurope74,000USD0001437749-25-016850
    Q1 2024Quarterly · 2024-03-31GeographyUnited States8,000USD0001437749-25-016850
    FY 2023Yearly · 2023-12-31GeographyEurope111,000USD0001437749-25-009918
    FY 2023Yearly · 2023-12-31GeographyUnited States331,000USD0001437749-25-009918
    FY 2023Yearly · 2023-12-31ProductProduct442,000USD0001437749-25-009918
    FY 2023Yearly · 2023-12-31ProductSoftware Upgrade Services0USD0001437749-25-009918
    Q2 2021Quarterly · 2021-06-30ProductProduct318,000USD0001564590-21-043513
    Q2 2021Quarterly · 2021-06-30ProductService Other687,000USD0001564590-21-043513
    Q2 2021Quarterly · 2021-06-30SegmentDermatology996,000USD0001564590-21-043513
    Q2 2021Quarterly · 2021-06-30SegmentVascular9,000USD0001564590-21-043513
    Q1 2021Quarterly · 2021-03-31ProductProduct406,000USD0001564590-21-026654
    Q1 2021Quarterly · 2021-03-31ProductService Other712,000USD0001564590-21-026654
    Q1 2021Quarterly · 2021-03-31SegmentDermatology1,114,000USD0001564590-21-026654
    Q1 2021Quarterly · 2021-03-31SegmentVascular4,000USD0001564590-21-026654
    Q4 2020Quarterly · 2020-12-31ProductProduct601,000USDLegacy provider
    Q4 2020Quarterly · 2020-12-31ProductService Other1,462,000USDLegacy provider
    Q4 2020Quarterly · 2020-12-31SegmentDermatology1,217,000USDLegacy provider
    Q4 2020Quarterly · 2020-12-31SegmentVascular0USDLegacy provider
    FY 2020Yearly · 2020-12-31GeographyInternational224,000USD0001564590-21-013653
    FY 2020Yearly · 2020-12-31GeographyUnited States4,181,000USD0001564590-21-013653
    FY 2020Yearly · 2020-12-31ProductProduct254,000USD0001564590-22-011555
    FY 2020Yearly · 2020-12-31ProductService Other5,000USD0001564590-22-011555
    FY 2020Yearly · 2020-12-31SegmentDermatology4,146,000USD0001564590-21-013653
    FY 2020Yearly · 2020-12-31SegmentVascular259,000USD0001564590-21-013653
    Q3 2020Quarterly · 2020-09-30ProductProduct66,000USD0001564590-21-057029
    Q3 2020Quarterly · 2020-09-30ProductService Other2,000USD0001564590-21-057029
    Q3 2020Quarterly · 2020-09-30SegmentDermatology846,000USD0001564590-20-053939
    Q3 2020Quarterly · 2020-09-30SegmentVascular68,000USD0001564590-20-053939
    Q2 2020Quarterly · 2020-06-30ProductProduct154,000USD0001564590-21-043513
    Q2 2020Quarterly · 2020-06-30ProductService Other746,000USD0001564590-21-043513
    Q2 2020Quarterly · 2020-06-30SegmentDermatology822,000USD0001564590-21-043513
    Q2 2020Quarterly · 2020-06-30SegmentVascular78,000USD0001564590-21-043513
    Q1 2020Quarterly · 2020-03-31SegmentDermatology1,261,000USD0001564590-21-026654
    Q1 2020Quarterly · 2020-03-31SegmentVascular113,000USD0001564590-21-026654
    Q4 2019Quarterly · 2019-12-31SegmentDermatology1,236,000USDLegacy provider
    Q4 2019Quarterly · 2019-12-31SegmentVascular154,000USDLegacy provider
    FY 2019Yearly · 2019-12-31GeographyInternational631,000USD0001564590-21-013653
    FY 2019Yearly · 2019-12-31GeographyUnited States6,568,000USD0001564590-21-013653
    FY 2019Yearly · 2019-12-31ProductProduct3,859,000USD0001564590-21-013653
    FY 2019Yearly · 2019-12-31ProductService Other3,340,000USD0001564590-21-013653
    FY 2019Yearly · 2019-12-31SegmentDermatology5,924,000USD0001564590-21-013653
    FY 2019Yearly · 2019-12-31SegmentVascular1,275,000USD0001564590-21-013653
    FY 2018Yearly · 2018-12-31GeographyInternational422,000USD0001564590-20-010123
    FY 2018Yearly · 2018-12-31GeographyUnited States5,835,000USD0001564590-20-010123
    FY 2018Yearly · 2018-12-31ProductProduct3,159,000USD0001564590-20-010123
    FY 2018Yearly · 2018-12-31ProductService Other3,098,000USD0001564590-20-010123
    FY 2018Yearly · 2018-12-31SegmentDermatology4,705,000USD0001564590-20-010123
    FY 2018Yearly · 2018-12-31SegmentVascular1,552,000USD0001564590-20-010123
    FY 2017Yearly · 2017-12-31GeographyInternational597,000USD0001564590-19-007905
    FY 2017Yearly · 2017-12-31GeographyUnited States5,273,000USD0001564590-19-007905
    FY 2017Yearly · 2017-12-31ProductProduct3,067,000USD0001564590-19-007905
    FY 2017Yearly · 2017-12-31ProductService Other2,803,000USD0001564590-19-007905
    FY 2017Yearly · 2017-12-31SegmentDermatology5,611,000USD0001564590-19-007905
    FY 2017Yearly · 2017-12-31SegmentVascular259,000USD0001564590-19-007905

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.